Abstracts

LIVER NEUTROPHILS EXPRESS STRONGER PD-L1 SIGNALING IN HIV/HBV COMPARED TO HBV ALONE

Background: HIV coinfection accelerates the natural history of hepatitis B infection (HBV); however, precise mechanisms for this are not fully understood, in part because the site of infection – the liver – is difficult to access. Further, patients with HIV/HBV coinfection may experience robust anti-HBV immune responses when starting antiretroviral therapy. In Zambia, where HIV/HBV…

PBPK MODEL PREDICTION OF LONG-ACTING CAB AND RPV CONCENTRATIONS IN PREGNANCY

Background: The pharmacokinetics (PK) of cabotegravir (CAB) long-acting and rilpivarine (RPV) long-acting has not been prospectively studied in pregnancy. Physiologically-based pharmacokinetic models (PBPK) offer the ability to incorporate physiologic pregnancy-associated changes and drug specific characteristics to predict the concentration exposure during pregnancy. Methods: We used a published maternal-fetal PBPK model by Dallmann et. al. in…

HIGH PANDEMIC-RELATED MORTALITY AMONGST PEOPLE WITH HIV IN SASKATCHEWAN, CANADA

Background: Saskatchewan, a Canadian Prairie province, faces a complicated HIV epidemic characterized by high rates of transmission due to injection drug use (IDU) and disproportionate representation of younger persons, women, and persons of Indigenous ethnicity. HIV incidence in Saskatchewan in 2021 was 19.7 per 100,000, 4.5 times higher than the Canadian average. Concurrently, during the…

DNA-CONFIRMATION OF HIV-1&2 COINFECTIONS AMONG DUALLY-REACTIVE WEST AFRICAN PATIENTS

Background: West Africa is characterized by the co-circulation of HIV-1 and HIV-2, leading to co-infections with both viruses. ART-naïve patients co-infected with both viruses were reported to experience a higher mortality rate compared to HIV-2 mono-infected patients. The accurate diagnosis of this co-infection remains challenging for the national HIV testing algorithms of West African countries,…

PLITIDEPSIN IS A BROAD-SPECTRUM ANTIVIRAL SHAPING THE CELL PROTEOSTATIC BALANCE

Background: Different viruses employ similar pathways for replication, revealing key intracellular hotspots to target with host-directed therapies and achieve a broad-spectrum antiviral activity. Plitidepsin is a clinically approved antitumoral agent that blocks the elongation factor eEF1A required for protein translation. This drug counteracts SARS-CoV-2 replication and shows a favorable safety profile in COVID-19 patients. Yet,…

SARS-CoV-2 SEROPREVALENCE AMONG UGANDAN BLOOD DONORS: 2019-2022

Background: COVID-19 in Africa was less severe with fewer reported cases, hospitalizations and deaths compared to other continents. However, the lack of adequate surveillance systems in Africa makes estimating the burden of infection challenging. Serosurveillance can aid in determining the frequency of infection within this population. This study is aimed to estimate SARS-CoV-2 seroprevalence, describe…

THE CIRCULATING CELL-FREE DNA METHYLOME PREDICTS HIV POST-TREATMENT CONTROL

Background: The development of HIV cure strategies depends on our capacity to predict HIV control when antiretroviral therapy (ART) is stopped. Motivated by the recent expansion of noninvasive cell-free DNA (cfDNA)-based cancer diagnostics, we performed multi-dimensional profiling of plasma cfDNA obtained from individuals who maintain HIV suppression following ART cessation termed post-treatment controllers (PTCs), to…